RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Influence of patient-reported outcomes on market access decisions in decentralized markets (Brazil, Italy, Spain, and the United States)
Hogue, S., Brogan, A., DeMuro, C., Barrett, A., D'Alessio, D., & Bal, V. (2015). Influence of patient-reported outcomes on market access decisions in decentralized markets (Brazil, Italy, Spain, and the United States). Value in Health, 18(3), A212-A212. https://doi.org/10.1016/j.jval.2015.03.1229
To determine how impactful patient-reported outcome (PRO) data from clinical trial programs are on market access decision making in oncology and other disease areas in decentralized markets.